Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm

被引：4
|
作者：
Castiglione, Melissa [1 ]
Zhang, Haotian [2 ]
Kaushansky, Kenneth [3 ]
Zhan, Huichun [1 ,4 ]
机构：
[1] Stony Brook Sch Med, Dept Med, HSC T15,Room 053, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Grad Program Mol & Cellular, Stony Brook, NY 11794 USA
[3] Stony Brook Sch Med, Hlth Sci, Stony Brook, NY USA
[4] Northport VA Med Ctr, Med Serv, Northport, NY 11768 USA
来源：
EXPERIMENTAL HEMATOLOGY | 2021年 / 100卷
关键词：
HEMATOPOIETIC STEM; ENDOTHELIAL-CELLS; CLONAL HEMATOPOIESIS; SOMATIC MUTATIONS; PROGENITOR CELLS; TRANSPLANTATION; MYELOFIBROSIS; EXPANSION; CANCER; CONTRIBUTES;
D O I：
10.1016/j.exphem.2021.06.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：52 / 62
页数：11
相关论文
共 50 条
  • [31] Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
    Marty, Caroline
    Lacout, Catherine
    Martin, Antoine
    Hasan, Salma
    Jacquot, Sylvie
    Birling, Marie-Christine
    Vainchenker, William
    Villeval, Jean-Luc
    BLOOD, 2010, 116 (05) : 783 - 787
  • [32] Evaluation of JAK2V617F mutation prevalence in myeloproliferative neoplasm by AS-RT-PCR
    Karimzadeh, P.
    Ghaffari, S. H.
    Chahardouli, B.
    Zaghal, A.
    Einollahi, N.
    Mousavi, S. A.
    Bahar, B.
    Dargahi, H.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    Togheh, G. R.
    Nadali, F.
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 1 (02) : 38 - 42
  • [33] Stat3 Negatively Regulates Myeloproliferative Neoplasm Induced By Jak2V617F
    Yan, Dongqing
    Mohi, Golam
    BLOOD, 2013, 122 (21)
  • [34] PREVALENCE OF JAK2V617F MUTATION AND ITS CLINICAL CORRELATION IN THAIS WITH MYELOPROLIFERATIVE NEOPLASM
    Chanprasert, S.
    Suksomyos, N.
    Maunpasitporn, C.
    Ponlapat, R.
    HAEMATOLOGICA, 2012, 97 : 643 - 643
  • [35] Characterizing the Disease-Initiating Cell Population In a Murine Model of Jak2V617F+Myeloproliferative Neoplasm
    Mullally, Ann
    Lane, Steven W.
    Poveromo, Luke
    Al-Shahrour, Fatima
    Kutok, Jeffery
    Ebert, Benjamin L.
    BLOOD, 2010, 116 (21) : 144 - 145
  • [36] Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2V617F mutation
    Yasuda, Shunichiro
    Chiba, Momoko
    Nishitani, Rie
    Watanabe, Takako
    CLINICAL CASE REPORTS, 2024, 12 (04):
  • [37] JAK2V617F mutation and thrombosis in the myeloproliferative neoplasms
    Demirkan, F.
    Kalkan, S.
    Kahraman, S.
    Tunali, S.
    Katgi, A.
    Piskin, O.
    Ozcan, M. A.
    Ozsan, H. G.
    Undar, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 890 - 890
  • [38] Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F
    Gery, Sigal
    Cao, Qi
    Gueller, Saskia
    Xing, Hongtao
    Tefferi, Ayalew
    Koeffler, H. Phillip
    JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 85 (06) : 957 - 965
  • [39] Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation
    Sun, Tiantian
    Zhang, Lei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (04) : 374 - 381
  • [40] Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm
    Helman, Ricardo
    Pereira, Welbert de O.
    Marti, Luciana C.
    Campregher, Paulo V.
    Puga, Renato Davi
    Hamerschlak, Nelson
    Chiattone, Carlos S.
    Santos, Fabio Pires de S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (03) : 443 - 445
12345